Bezafibrate for X-Linked Adrenoleukodystrophy

• Marc Engelen,

  Affiliations Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Pediatric Neurology/Emma Children’s Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Luc Tran,

  Affiliation Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Rob Ofman,

  Affiliation Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Josephine Brennecke,

  Affiliation Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Ann B. Moser,

  Affiliation Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, United States of America

  ⨯
• Inge M. E. Dijkstra,

  Affiliation Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Ronald J. A. Wanders,

  Affiliation Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Bwee Tien Poll-The,

  Affiliations Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Pediatric Neurology/Emma Children’s Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Stephan Kemp

  * E-mail: s.kemp@amc.uva.nl

  Affiliations Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Department of Pediatric Neurology/Emma Children’s Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

  ⨯